Scopolamine Patch, Extended Release
Product Images NDC 42858-150

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 42858-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Scopolamine 01)

FDA Label Image

Image (Scopolamine 02)

Image (Scopolamine 02)
The text describes different layers of a drug delivery system: Backing Membrane, Drug Layer, Rate Controlling Membrane, and Contact Layer. It also mentions a "Release Liner". These layers are likely part of a transdermal patch or a similar drug delivery device.*
FDA Label Image

Figure 1 (Scopolamine 03)

Figure 1 (Scopolamine 03)
This text appears to describe a disposable release liner with a metallic adhesive surface, a tan backing membrane with an imprint that reads "Scopolamine 1mg/3 days". It may be referring to a medical or pharmaceutical product.*
FDA Label Image

Figure 2 (Scopolamine 04)

FDA Label Image

Figure 3 (Scopolamine 05)

FDA Label Image

Figure 4 (Scopolamine 06)

Figure 4 (Scopolamine 06)
This text describes a tan-colored transdermal system with a metallic adhesive surface. It also mentions a clear, disposable release liner. The system seems to be imprinted and has a figure labeled as "Figure 4".*
FDA Label Image

Figure 5 (Scopolamine 07)

Figure 5 (Scopolamine 07)
This is a tan-colored transdermal system with an imprint. The design or pattern on the system is detailed in Figure 5.*
FDA Label Image

Principal Display Panel (4 Patch Pouch Box)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.